Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ibis Biosciences Inc.

Division of Abbott Laboratories Inc.
www.ibisbiosciences.com

Latest From Ibis Biosciences Inc.

Lyme Disease: Has Big Pharma Stopped The Clock On A Cure?

Though vastly underreported, new cases of Lyme in the US total more than 300,000 a year; its incidence now exceeds infections for far more visible conditions like HIV. A higher profile for Lyme is hobbled by a slow and distorted institutional response, especially among clinicians who disagree on whether Lyme is one disease or a complex constellation of many – much like cancer, but without the commitment.

BioPharmaceutical Infectious Diseases

Battling Infection: Hospitals Seek High-Tech Solutions

The market for diagnostic and infection control products will see continued growth as hospitals and other providers look to the technology sector to help fight the battle against health care-associated infections and antibiotic-resistant organisms.

Medical Device

Battling Infection: Hospitals Seek High-Tech Solutions

The market for diagnostic and infection control products will see continued growth as hospitals and other providers look to the technology sector to help fight the battle against health care-associated infections and antibiotic-resistant organisms.

Medical Device Innovation

Deals Of The Week: Isis Rethinks Its Partnering Strategy

Capitalizing on the interest that partners are showing in its beefed-up antisense pipeline, Isis has reset its partnering strategy to maximize the value of each asset. In other developments, Ensemble snagged Novartis in a discovery collaboration and Amgen returned glucokinase activator AMG 151 to Array.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ibis Therapeutics
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • David J Ecker, PhD, CSO
    Steven Hofstadler, PhD, VP, Rsch.
    Michael Treble, Pres.
  • Contact Info
  • Ibis Biosciences Inc.
    Phone: (760) 268-6767
    1896 Rutherford Rd.
    Carlsbad, CA 92008
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register